Abbott’s ARCHITECT STAT High Sensitivity Troponin-I Blood Test Receives FDA Clearance to Detect Heart Attacks Faster and Accurately

 Abbott’s ARCHITECT STAT High Sensitivity Troponin-I Blood Test Receives FDA Clearance to Detect Heart Attacks Faster and Accurately

Abbott’s ARCHITECT STAT High Sensitivity Troponin-I Blood Test Receives FDA Clearance to Detect Heart Attacks Faster and more Accurately

Shots:

  • Abbott’s High Sensitivity Troponin-I blood test measures very low levels of troponin, allowing doctors to evaluate heart attack in patients within 2-4 hrs. of admission as the elevated level of Troponin-I proteins in the blood indicates cardiac muscles damage and improves the diagnosis in women
  • Abbott’s blood test is evaluated in 200+ studies for its role in identifying heart disease and cardiac events without affected by biotin interference. Abbott will launch the Heart Partnership Program which aid hospital care teams to implement blood test into their care pathway
  • The High Sensitivity Troponin I blood test is used on ARCHITECT analyzer along with ECG, clinical observations and information and patient symptoms to aid heart attack diagnosis

Click here to­ read full press release/ article | Ref: Abbott | Image: Selbys

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post